These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6169480)

  • 1. Comparison of intrarenal and extrarenal converting-enzyme inhibition by SQ 20 881 on canine renal blood flow.
    Wong PC; Zimmerman BG
    Clin Sci (Lond); 1981 Nov; 61(5):553-7. PubMed ID: 6169480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effect of intrarenal converting enzyme inhibition on canine renal blood flow.
    Zimmerman BG; Wong PC; Kounenis GK; Kraft EJ
    Am J Physiol; 1982 Aug; 243(2):H277-83. PubMed ID: 6180643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs.
    Kimbrough HM; Vaughan ED; Carey RM; Ayers CR
    Circ Res; 1977 Feb; 40(2):174-8. PubMed ID: 191213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of systemic and intrarenal converting enzyme inhibition by MK-422 on renal hemodynamics in conscious dogs.
    Zimmerman BG; Finis CJ
    J Cardiovasc Pharmacol; 1985; 7(4):715-22. PubMed ID: 2410713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal by angiotensins II and III of the effects of converting enzyme inhibition on renal electrolyte excretion in rats.
    Harris PJ; Munro JO
    J Physiol; 1984 Jun; 351():491-500. PubMed ID: 6205144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of SQ 20881 and captopril on mesenteric, renal, and iliac vasculatures.
    Fiksen-Olsen MJ; Britton SL; Houck PC; Romero JC
    Am J Physiol; 1983 Mar; 244(3):H313-9. PubMed ID: 6187226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accentuated vascular and endocrine response to SQ 20881 in hypertension.
    Williams GH; Hollenberg NK
    N Engl J Med; 1977 Jul; 297(4):184-8. PubMed ID: 195203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of angiotensin inhibition and renal denervation in two-kidney, one clip hypertensive rats.
    Rademacher R; Berecek KH; Ploth DW
    Hypertension; 1986 Dec; 8(12):1127-34. PubMed ID: 3025089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of converting enzyme inhibitor (SQ 20881) on changes in blood pressure and plasma aldosterone induced by angiotensin I or acute hemorrhage in rabbits.
    Saito I; Eguchi T; Nakamura R; Misumi J; Kondo K; Saruta T
    Jpn Heart J; 1980 Jan; 21(1):95-101. PubMed ID: 6154159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of inhibition of peptidase activity on distribution of intrarenal blood flow.
    Bailie MD; Barbour JA
    Am J Physiol; 1975 Mar; 228(3):850-3. PubMed ID: 163595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of blood pressure reduction by teprotide (SQ 20881) in rats.
    Jaeger P; Ferguson RK; Brunner HR; Kirchertz EJ; Gavras H
    Kidney Int; 1978 Apr; 13(4):289-96. PubMed ID: 651128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intrarenal blockade of the renin-angiotensin system in the conscious dog.
    Siragy HM; Howell NL; Peach MJ; Carey RM
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F522-9. PubMed ID: 2180318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for the local occurrence of angiotensin II in rat kidney and its modulation by dietary sodium intake and converting enzyme blockade.
    Mendelsohn FA
    Clin Sci (Lond); 1979 Aug; 57(2):173-9. PubMed ID: 477254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of verapamil and converting enzyme inhibition on bilateral renal function of two-kidney, one-clip hypertensive rats.
    Ploth DW; Kleeman K; Morrill L; Rademacher R; Jackson CA
    Clin Sci (Lond); 1987 Jun; 72(6):657-67. PubMed ID: 3036414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tubuloglomerular feedback and single nephron function after converting enzyme inhibition in the rat.
    Ploth DW; Rudulph J; LaGrange R; Navar LG
    J Clin Invest; 1979 Nov; 64(5):1325-35. PubMed ID: 227932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of the renal responses to bradykinin by inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in anesthetized dogs.
    Seymour AA; Sheldon JH; Smith PL; Asaad M; Rogers WL
    J Pharmacol Exp Ther; 1994 Apr; 269(1):263-70. PubMed ID: 8169834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermal responses to central angiotensin II, SQ 20881, and dopamine infusions in sheep.
    Huang BS; Kluger MJ; Malvin RL
    Am J Physiol; 1985 Mar; 248(3 Pt 2):R371-7. PubMed ID: 3976911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal vascular and biochemical responses to systemic renin inhibition in dogs at low renal perfusion pressure.
    Clozel JP; Véniant MM; Qiu C; Sprecher U; Wolfgang R; Fischli W
    J Cardiovasc Pharmacol; 1999 Nov; 34(5):674-82. PubMed ID: 10547083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a primary antidiuretic action of angiotensin II: effects of intrarenal converting enzyme inhibition in the conscious dog.
    Levens NR; Peach MJ; Vaughan ED; Carey RM
    Endocrinology; 1981 Jan; 108(1):318-30. PubMed ID: 6161801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Threshold sodium excretory and renal blood flow effects of angiotensin converting enzyme inhibition.
    Zhang X; Dunham EW; Zimmerman BG
    J Hypertens; 1995 Dec; 13(12 Pt 1):1413-19. PubMed ID: 8866903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.